Issue of Options and Director/PDMR Notification
Updated : 07:04
20 April 2020
Aquis Exchange PLC
("Aquis", the "Company" or the "Group")
Issue of Options
and
Director/PDMR Notification
Aquis Exchange PLC (AQX.L), the exchange services group, announces that on 17 April 2020 it issued a total of 737,250 options ("Options") over the Company's ordinary shares of 10p each ("Ordinary Shares") to Directors and employees of the Company. 80,000 Options were issued to each of Alasdair Haynes, CEO of the Company, and Jonathan Clelland, CFO and COO of the Company.
The Options were granted under the Company's existing EMI plan and have an exercise price of £3.47, which is the closing mid-market price of the Company's existing ordinary shares on 16 April 2020, the latest practicable date prior to the issue of the Options. The Options will vest in tranches of one third on the first, second and third anniversary of the date of issue and expire 10 years from the date of issue. Vesting or exercise of the Options is not dependent on performance criteria.
Following the grant of the Options, the total number of Ordinary Shares outstanding under all Group EMI option schemes is 1,276,281, representing 4.7 per cent. of the Company's issued share capital.
Enquiries:
Aquis Exchange PLC | Tel: +44 (0)20 3597 6321 |
Alasdair Haynes, CEO | |
Jonathan Clelland, CFO and COO Belinda Keheyan, Head of Marketing |
Tel: +44 (0)20 3597 6329 |
Liberum Capital Limited (Nominated Adviser and Broker) | Tel: +44 (0)20 3100 2000 |
Clayton Bush | |
Chris Clarke | |
Edward Thomas | |
Kane Collings | |
Alma PR (Financial PR Adviser) | Tel: +44 (0)20 3405 0205 |
Caroline Forde | aquis@almapr.co.uk |
Susie Hudson Rebecca Sanders-Hewett | |
Notes to editors:
Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).
Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.
Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue.
Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.
Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Alasdair Haynes | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Executive Officer | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Aquis Exchange PLC | ||||
b)
| LEI
| 213800IXJSF5E1SIW150 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Options over Ordinary shares of 10 pence each
ISIN: GB00BD5JNK30 | ||||
b)
| Nature of the transaction
| Grant of share options under the Company's EMI option scheme
| ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume - Price |
N/A £3.47
| ||||
e)
| Date of the transaction
| 17 April 2020 | ||||
f)
| Place of the transaction
| Outside a trading venue |
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Jonathan Clelland | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Chief Financial Officer and Chief Operating Officer | ||||
b)
| Initial notification /Amendment
| Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Aquis Exchange PLC | ||||
b)
| LEI
| 213800IXJSF5E1SIW150 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Options over Ordinary shares of 10 pence each
ISIN: GB00BD5JNK30 | ||||
b)
| Nature of the transaction
| Grant of share options under the Company's EMI option scheme
| ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume - Price |
N/A £3.47
| ||||
e)
| Date of the transaction
| 17 April 2020 | ||||
f)
| Place of the transaction
| Outside a trading venue |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.